文献速递慢性肾脏病

澳大利亚初级保健中慢性肾脏病的患病率:全国全科医学数据集分析

The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset.
PubMed 文献 · Kidney Int Rep · 2023-11-29

该回顾性观察研究基于MedicineInsight项目2011–2020年2,720,529名有血清肌酐检测的成人,采用三种严格程度不同的CKD定义估算患病率。2020年CKD患病率按最宽松、中等和最严格定义分别为8.4%、4.7%和3.1%,且10年间呈上升趋势。同时检测eGFR和UACR的患者多处于中高进展风险。

要点

  • 2020年CKD患病率随定义严格程度不同为8.4%、4.7%和3.1%。
  • 10年研究期间CKD患病率呈持续上升趋势,与定义方法无关。
  • 仅少数CKD患者同年有eGFR和UACR双项检测,多数属中高进展风险。

核心结论

  • 澳大利亚初级保健中CKD患病率呈上升趋势,多数CKD患者处于中高进展风险。

研究设计与样本

  • 回顾性社区观察研究,纳入2011–2020年就诊于MedicineInsight全科诊所且有至少一次血清肌酐检测的2,720,529名成人。

主要发现

  • 2020年CKD患病率按最宽松、中等和最严格定义分别为8.4%、4.7%和3.1%。
  • 10年研究期间CKD患病率不论采用何种定义方法均呈逐步上升。
  • 2020年CKD患者中同年同时有eGFR和UACR检测者分别仅3.8%、3.2%和1.5%。
  • 同时有eGFR和UACR检测的患者中,多数处于中高CKD进展风险(83.6%、80.6%和76.2%)。

临床怎么用

  • 初级保健中应重视CKD早期检测,并加强eGFR与UACR联合评估以识别中高进展风险患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The prevalence of chronic kidney disease (CKD) in Australia varies substantially across reports. Using a large, nationally representative general practice data source, we determined the contemporary prevalence and staging of CKD in the Australian primary care. METHODS: We performed a retrospective, community-based observational study of 2,720,529 adults with ≥1 visit to a general practice participating in the MedicineInsight program and ≥1 serum creatinine measurement (with or without a urine albumin-to-creatinine ratio [UACR] measurement) between 2011 and 2020. CKD prevalence was estimated using 3 definitions based on estimated glomerular filtration rate (eGFR) and UACR measurements with varying degrees of rigidity in terms of the number of measurements assessed to define CKD ("least", "moderate" and "most" rigid). RESULTS: CKD prevalence in the cohort progressively increased over the 10-year study period, irrespective of the method used to define CKD. In 2020, CKD prevalence in the cohort was 8.4%, 4.7%, and 3.1% using the least, moderate, and most rigid definition, respectively. The number of patients with UACR measurements was low such that, among those with CKD in 2020, only 3.8%, 3.2%, and 1.5%, respectively, had both eGFR and UACR measurements available in the corresponding year. Patients in whom both eGFR and UACR measurements were available mostly had moderate or high risk of CKD progression (83.6%, 80.6%, and 76.2%, respectively). CONCLUSION: In this large, nationally representative study, we observed an increasing trend in CKD prevalence in primary care settings in Australia. Most patients with CKD were at moderate to high risk of CKD progression. These findings highlight the need for early detection and effective management to slow progression of CKD.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Jun M, Wick J, Neuen BL, et al. The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset. Kidney Int Rep. 2023. PMID: 38344725. doi:10.1016/j.ekir.2023.11.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。